Pluri Inc., a biotechnology company, focuses on the development of placenta-based cell therapy product candidates for the treatment of multiple inflammatory, mu…
$1.24+3.82%
报价 2026-11-06
市值
$13.3M
EV
$43.5M
PE (TTM)
–
预期 PE
–
52 周区间距高点 -72.2%
$0.85$4.45
筛选结果
pipeline · 2026-11-06Filter✗ 高增长✗ Cheap✗ GARP
excluded industry: Biotechnology
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
同行业市值相近 · Biotechnology| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| PLURPluri Inc. | $13.3M | +3.8% | – | 44.6% | – | – | – | |
| DYAIDyadic International, Inc. | $13.6M | -0.1% | +71.8% | 30.4% | – | – | – | |
| LPCNLipocine Inc. | $12.9M | +2.6% | -33.3% | -8.2% | – | – | – | |
| BCDABioCardia, Inc. | $12.9M | -4.5% | 0.0% | 0% | – | – | – | |
| PASGPassage Bio, Inc. | $12.8M | +14.9% | +5.3% | 0% | – | – | – | |
| TVRDTvardi Therapeutics, Inc. | $12.8M | +10.8% | -100.0% | 0% | – | – | – | |
| BOLTBolt Biotherapeutics, Inc. | $12.6M | +2.5% | -66.1% | 95.7% | – | – | – | |
| PLRZPolyrizon Ltd. | $12.4M | -4.7% | – | 0% | – | – | – | |
| GUTSFractyl Health, Inc. Common Stock | $12.3M | +3.8% | +153.1% | 0% | – | – | – | |
| 同行中位数 | – | – | 0.0% | 0% | – | – | – |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据（首次研究运行后填充）。